{"id":"drug-cimetidine","safety":{"commonSideEffects":[{"rate":"2-4","effect":"Headache"},{"rate":"1-2","effect":"Diarrhea"},{"rate":"1-2","effect":"Dizziness"},{"rate":"0.1-1","effect":"Gynecomastia"},{"rate":"1-2","effect":"Elevated serum creatinine"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cimetidine is a competitive antagonist of histamine H2 receptors, which are responsible for stimulating gastric acid secretion. By blocking these receptors, it decreases both basal and stimulated acid production in the stomach. This mechanism makes it effective for treating acid-related gastrointestinal disorders.","oneSentence":"Cimetidine blocks histamine H2 receptors on gastric parietal cells to reduce stomach acid production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:45:04.744Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Duodenal ulcer"},{"name":"Gastric ulcer"},{"name":"Gastroesophageal reflux disease (GERD)"},{"name":"Zollinger-Ellison syndrome"},{"name":"Peptic ulcer disease"}]},"trialDetails":[{"nctId":"NCT03495232","phase":"","title":"Persona Cohort Nordic Multicenter Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zimmer Biomet","startDate":"2016-11-01","conditions":"Knee Arthropathy","enrollment":700},{"nctId":"NCT04862585","phase":"PHASE2, PHASE3","title":"Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2021-10-07","conditions":"Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8","enrollment":130},{"nctId":"NCT06971497","phase":"","title":"Zimmer ActivBraid Rotator Cuff Repair (RCR) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-08-11","conditions":"Rotator Cuff Repair of the Shoulder","enrollment":65},{"nctId":"NCT05365451","phase":"EARLY_PHASE1","title":"Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters","status":"COMPLETED","sponsor":"Washington State University","startDate":"2022-04-11","conditions":"Interaction, Endogenous Biomarkers","enrollment":16},{"nctId":"NCT05391451","phase":"NA","title":"New Approach of Loco Regional Analgesia in Kidney Transplant","status":"COMPLETED","sponsor":"CHU de Reims","startDate":"2021-08-31","conditions":"Chronic Kidney Diseases","enrollment":48},{"nctId":"NCT06107829","phase":"PHASE4","title":"Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities","status":"WITHDRAWN","sponsor":"Stephen Ruedrich","startDate":"2025-01","conditions":"Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities","enrollment":""},{"nctId":"NCT06056583","phase":"PHASE4","title":"Drug Excretion in Breast Milk","status":"RECRUITING","sponsor":"University of Washington","startDate":"2023-12-04","conditions":"Postpartum, Lactation, Drugs in Breast Milk","enrollment":50},{"nctId":"NCT04868305","phase":"NA","title":"Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures","status":"UNKNOWN","sponsor":"Helse Stavanger HF","startDate":"2021-10-12","conditions":"Hip Injuries and Disorders, Hip Fractures","enrollment":170},{"nctId":"NCT05881811","phase":"PHASE1","title":"The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subjects","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2023-03-20","conditions":"PHN - Post-Herpetic Neuritis","enrollment":47},{"nctId":"NCT05673590","phase":"PHASE3","title":"Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","status":"UNKNOWN","sponsor":"Beijing Biostar Pharmaceuticals Co., Ltd.","startDate":"2023-05-12","conditions":"Locally Advanced or Metastatic Non-Small Cell Lung Cancer","enrollment":612},{"nctId":"NCT03307252","phase":"PHASE1","title":"This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-10-25","conditions":"Healthy","enrollment":45},{"nctId":"NCT05922358","phase":"PHASE2","title":"Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors","status":"NOT_YET_RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2023-09-01","conditions":"Gastrointestinal Tumors","enrollment":500},{"nctId":"NCT03541408","phase":"NA","title":"Preventative Delirium Protocol in Elderly Patients","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2016-05-01","conditions":"Delirium","enrollment":263},{"nctId":"NCT04493931","phase":"PHASE1","title":"Drug-drug Interaction Study of Gepotidacin","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2020-08-14","conditions":"Infections, Bacterial","enrollment":64},{"nctId":"NCT02287272","phase":"PHASE1","title":"Drug-drug Interaction Study of CHF5993 With Cimetidine","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-05","conditions":"COPD","enrollment":25},{"nctId":"NCT03201796","phase":"PHASE2","title":"Prulifloxacin in Chronic Bacterial Prostatitis (CBP)","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2016-02-02","conditions":"Chronic Bacterial Prostatitis","enrollment":168},{"nctId":"NCT01010698","phase":"PHASE1","title":"Class 3 Biowaivers","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2009-06","conditions":"Healthy","enrollment":48},{"nctId":"NCT04280185","phase":"NA","title":"HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC)","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-06-01","conditions":"Ovarian Cancer, Hyperthermic Intraperitoneal Chemotherapy","enrollment":202},{"nctId":"NCT04018131","phase":"PHASE3","title":"The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy","status":"UNKNOWN","sponsor":"Fakultas Kedokteran Universitas Indonesia","startDate":"2018-03-26","conditions":"Atopic Dermatitis, Immunoglobulin E Concentration, Serum","enrollment":26},{"nctId":"NCT01256879","phase":"PHASE4","title":"Cimetidine Biowaivers","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2011-03","conditions":"Healthy","enrollment":25},{"nctId":"NCT03618316","phase":"PHASE1","title":"Effect of Cimetidine on the PK of Imeglimin","status":"COMPLETED","sponsor":"Poxel SA","startDate":"2018-06-19","conditions":"Healthy","enrollment":16},{"nctId":"NCT02669303","phase":"NA","title":"Platelet-rich Plasma (PRP) Injection for Treating Shoulder Subacromial Impingement Syndrome","status":"TERMINATED","sponsor":"American University of Beirut Medical Center","startDate":"2015-09","conditions":"Shoulder Impingement Syndrome","enrollment":19},{"nctId":"NCT02703896","phase":"PHASE4","title":"Prophylaxis for Aspiration of Gastric Contents.","status":"COMPLETED","sponsor":"King Saud University","startDate":"2012-01","conditions":"Pulmonary Aspiration of Gastric Contents","enrollment":1920},{"nctId":"NCT02555852","phase":"","title":"Proton Pump Inhibitors and Risk of Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2011-09","conditions":"Gastroesophageal Reflux Disease (GERD), Community-acquired Pneumonia","enrollment":4238504},{"nctId":"NCT01953536","phase":"PHASE2","title":"Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)","status":"WITHDRAWN","sponsor":"Endocyte","startDate":"2014-04","conditions":"Breast Neoplasms","enrollment":""},{"nctId":"NCT01536249","phase":"PHASE1","title":"Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)","status":"COMPLETED","sponsor":"Knopp Biosciences","startDate":"2012-03","conditions":"Amyotrophic Lateral Sclerosis","enrollment":14},{"nctId":"NCT01087021","phase":"PHASE1","title":"Effect of Cabazitaxel on the QTc Interval in Cancer Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-03","conditions":"Neoplasms, Malignant","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":54,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tagamet"],"phase":"marketed","status":"active","brandName":"Drug: cimetidine","genericName":"Drug: cimetidine","companyName":"University of Maryland, Baltimore","companyId":"university-of-maryland-baltimore","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cimetidine blocks histamine H2 receptors on gastric parietal cells to reduce stomach acid production. Used for Duodenal ulcer, Gastric ulcer, Gastroesophageal reflux disease (GERD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}